OrganOx Newsroom

Welcome to our news feed, featuring the latest OrganOx updates as well as important news in the field of organ transplantation.

Press Release - Aug 21, 2026

NICE Supports Routine NHS Funding and Access to Ex-Situ Machine Perfusion in a Major Step Forward for Liver Transplantation

NICE Supports Routine NHS Funding and Access to Ex-Situ Machine Perfusion in a Major Step Forward for Liver Transplantation

OrganOx Announces Appointment of Naoya Iwata as CEO

Press Release - May 14, 2026

OrganOx Announces Appointment of Naoya Iwata as CEO & President

OrganOx Announces Appointment of Naoya Iwata as CEO

OrganOx Announces Appointment of Naoya Iwata as CEO & President

Press Release - Oct 30, 2025

OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation

OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation

News - Sep 18, 2025

OrganOx metra® Receives FDA Approval for Operation During Air Transport, Expanding Access to Life-Saving Liver Perfusion Technology

OrganOx metra® Receives FDA Approval for Operation During Air Transport, Expanding Access to Life-Saving Liver Perfusion Technology

News - Aug 24, 2025

Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector

Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector

News - Jul 09, 2025

OrganOx Honoured as Winner of the 2025 MacRobert Award for UK Engineering Innovation

OrganOx Honoured as Winner of the 2025 MacRobert Award for UK Engineering Innovation

News - May 08, 2025

OrganOx Announces Second Private Placement Closing, Investments by Intuitive Ventures and Terumo Ventures

OrganOx Announces Second Private Placement Closing, Investments by Intuitive Ventures and Terumo Ventures

Press Release - Apr 15, 2025

eGenesis and OrganOx Announce U.S. FDA Clearance of IND Application for the Treatment of Patients with Acute-On-Chronic Liver Failure

eGenesis and OrganOx Announce U.S. FDA Clearance of IND Application for the Treatment of Patients with Acute-On-Chronic Liver Failure

Press Release - Mar 17, 2025

OrganOx and ProCure On-Demand Announce Partnership to Expand Access for Liver Transplants

OrganOx and ProCure On-Demand Announce Partnership to Expand Access for Liver Transplants

test

News - Feb 04, 2025

OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital

test

OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital

News - Nov 12, 2024

OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting

OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting

News - Oct 02, 2024

OrganOx metra® System Licensed for Liver Transplantation in Canada

OrganOx metra® System Licensed for Liver Transplantation in Canada